(Q40122830)

17 September 2017

title

Interim futility analysis with intermediate endpoints (English)

1 reference

17 September 2017

Bryan Goldman

1

1 reference

17 September 2017

Michael LeBlanc

series ordinal

2

1 reference

17 September 2017

John Crowley

series ordinal

3

1 reference

17 September 2017

publication date

1 January 2008

1 reference

17 September 2017

1 reference

17 September 2017

volume

5

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

14-22

1 reference

A Multiple Testing Procedure for Clinical Trials

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Designs for group sequential tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Approximately optimal one-parameter boundaries for group sequential trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Surrogate end points in clinical trials: are we being misled?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507086648

21 January 2018

Identifiers

DOI

10.1177/1740774507086648

1 reference

17 September 2017

1 reference